Posts Tagged ‘Pemberton’

Seven year study of surgery for infective endocarditis: The contemporary Auckland City Hospital experience

Infective endocarditis remains a heterogeneous disease with high mortality, and surgery is required in approximately half for resultant heart failure, uncontrolled infection or embolism prevention. Several recent studies advocate operating early to have superior outcomes. We reviewed the characteristics, timing and outcomes of cardiac operations performed for infective endocarditis at Auckland City Hospital.

T. Wang, T. Oh, J. Voss, N. Kang, J. Pemberton
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland
Heart, Lung and Circulation – Volume 23, Supplement 1, e1-e48
Abstract & full-text available.

Features and outcomes of eosinophilic myocarditis: A single-centre case series

Eosinophilic myocarditis (EM) is a rare and potentially fatal entity characterised by inflammation with infiltrating eosinophils. Limited published data are available documenting presentation, management and prognosis. We report these data in a series of patients with EM treated at Auckland City Hospital.

T. Wang, T. Watson, B. Lowe, J. Pemberton, N. Kingston, C. Ellis, P. Ruygrok
Heart, Lung and Circulation – Volume 23, Supplement 1, e1-e48
Abstract & full-text available.

Trastuzumab induced cardiotoxicity in Auckland

Trastuzumab improves the prognosis of HER2 positive breast cancers but is associated with a decline in cardiac function. We looked at the incidence of Trastuzumab induced cardiotoxicity (TIC) in Auckland, defined as a reduction of LVEF of ≥5% to <55% with symptoms of heart failure or an asymptomatic reduction of the LVEF of ≥10% to <55%. K. Johnson, J. Signy, J. Pemberton, J. Cadogan Auckland City Hospital, Auckland Heart, Lung and Circulation - Volume 23, Supplement 1, e1-e48 Abstract & full-text available.

Interested in joining CSANZ?